Dicerna Pharmaceuticals, Inc.

Here is data found by MailMentor on Dicerna Pharmaceuticals, Inc.

Dicerna Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing medicines using ribonucleic acid interference (RNAi) to silence genes that cause various diseases. As a wholly owned subsidiary of Novo Nordisk, Dicerna is dedicated to driving advancements in the field of RNAi therapeutics. With a strong following of over 30,000 followers on LinkedIn, Dicerna Pharmaceuticals is committed to making a positive impact in the healthcare industry. Visit their corporate website for more information.

Find contacts at this company

Our AI enabled web scraper helps you prospects at Dicerna Pharmaceuticals, Inc. and similar companies

Find out how